期刊文献+

UGT1A3基因多态性与高血压肿瘤等疾病关系的研究

Association Analysis of the Relationship of UGT1A3 Gene Polymorphism to Hypertensive Disease or Tumor Disease
下载PDF
导出
摘要 目的研究UGT1A3基因多态性分布与高血压、肿瘤等疾病的关系。方法用焦磷酸测序法对UGT1A3单核苷酸多态性位点进行基因分型,研究UGT1A3基因多态性分布与高血压病、肿瘤和糖尿病的关系。结果高血压病和糖尿病患者组的UGT1A3突变基因频率与健康受试者组比较无显著性差异;肿瘤患者组UGT1A3-1、UGT1A3-2、UGT1A3-3和UGT1A3-4突变基因频率显著高于健康受试者组。提示UGT1A3-1、UGT1A3-2、UGT1A3-3和UGT1A3-4基因突变可能是肿瘤的易感基因。结论携带UGT1A3-1、UGT1A3-2、UGT1A3-3和UGT1A3-4突变基因者可能易患肿瘤;UGT1A3基因突变与高血压病和糖尿病无关。 Objective To study the association between UGT1 A3 gene polymorphism and hypertensive dis- ease or tumor disease. Methods The allelie frequency of the UGT1 A3 mutant was determined using pyrosequencing apparatus. The relationship of UGT1A3 gene polymorphism to hypertensive disease, tumor disease and diabetic dis- ease was studied. Results There was no significant difference in the allelic frequency of the UGT1A3 mutant be- tween hypertensive disease volunteers, diabetic disease volunteers and healthy volunteers. But there was significant difference between tumor disease volunteers and healthy volunteers. The UGT1A3-1, UGT1A3-2, UGT1A3-3 and UGT1A3-4 gene mutation were predisposing gene of tumor disease. Conclusion The gene mutation of UGT1A3-1, UGT1A3-2,UGT1A3-3 and UGT1A3-4 can increase the chance of tumor disease.
出处 《解放军药学学报》 CAS 2013年第1期5-8,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 UGT1A3 UGT基因多态性 基因突变 UGT1 A3 UGT polymorphism gene mutation
  • 相关文献

参考文献9

二级参考文献28

  • 1易娟,谢海棠,周宏灏.UGT1A9 C-2152T和UGT2B7 G211T突变在中国汉族人群中的分布[J].中国临床药理学与治疗学,2007,12(4):460-464. 被引量:9
  • 2YASUHIRO S, TOHRU G, TADAO S, et al. The effects of mitiglinide KAD1229, a new anti-diabetic drug, on ATP-sensitive K^+ channels and insulin secretion: comparison with the sulfony- lureas and nateglinide [ J]. Eur J Pharmacol, 2001, 431 ( 1 ) : 119 - 125.
  • 3YU L, LU S, LIN Y, et al. Carboxyl-glucuronidation of mitiglin- ide by human UDP-glucuronosyl transferases [ J ]. Biochem Phar- macol, 2007, 73 ( 11 ) : 1842 - 1851.
  • 4RARD C, BARBIER O, VEILLEUX G, et al. Human uridine diphosphate glucuronosyl transferase UGT2B7 conjugates minera|o- cortieoid and glueoeortieoid metabolites [ J ]. Endocrinology, 2003, 144(6) :2659 -2668.
  • 5COFFMAN BL, KING CD, RIOS GR, et al. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y (268) and UGT2B7H (268) [J]. Drug Metab Dispos, 1998, 26 (1) :73 -77.
  • 6Miners JO,Smith PA,Sorich MJ,et al.Preding human drug Glucuronidation Parameters:aPPlication of in vitro and in silico modeling approaches[J].Annu Rev Pharmaeol Tpxicol,2004,44 (3):1-25.
  • 7Rard C,Barbier O,Veilleux G,et al.Human uridine diphosphate glucuronosyl transferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites[J].Endocrinology,2003,144 (6):2659-2668.
  • 8Chen Y,Chen S,Li X,et al.Genetic Variants of Human UGT1 A3:Functional Characteization and Trequency Distribution in a Chines Han population[J].Drug Metab Dispos,2006,34 (7):1462-1467.
  • 9Yu L,Lu S,Lin Y,et al.Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyl transferases[J].Biochem Pharmacol,2007,73 (11):1842-1851.
  • 10Radominiska-Pandya A,Gzemik PJ,Little JM,et al.Structural and Functional studies of UGT-glucuronosyltransferases[J].Drug metabRev,1999,31 (7):817-899.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部